A trial of dasatinib for advanced cancers with certain gene changes (CA180385)

Overview

Cancer types:

All cancer types, Secondary cancers

Status:

Results

Phase:

Phase 2

Details

This trial looked at dasatinib for cancer that had spread into the surrounding tissue or to another part of the body. This is called advanced cancer. It was for people who had specific changes to called DDR2 and BRAF.

The trial was open for people to join between 2013 and 2014. The team analysed the results in 2016. There is a link to more information in the ‘Summary of results’ section below.

Recruitment start: 25 March 2013

Recruitment end: 16 September 2014